Tirabrutinib Maintenance Versus Placebo in Patients With Primary CNS Lymphoma in Complete Remission (JCOG2104)

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Tirabrutinib Maintenance Versus Placebo in Patients With Primary CNS Lymphoma in Complete Remission (JCOG2104)	primary central nervous system lymphoma	Recruiting	Phase 2	2026-08-05		NCT06940791

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Japan Clinical Oncology Group	7
Kyorin University	1
National Cancer Center, Japan	16
Ono Pharmaceutical Co., Ltd.	47

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Kyorin University Hospital	Tokyo	Japan	5

Clinical trials